Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

November 16, 2022

Infinant Health launches new HQ in Norwalk

PHOTO | Courtesy Infinant Health Infinant Health cuts the ribbon on its global executive headquarters in Norwalk. Pictured are David A. Mills, Kaile Zagger, Bruce German, Carlito Lebrilla, and Samara Freeman.

A company focused on babies’ well-being, Infinant Health, recently opened its new executive global headquarters in Norwalk.

The company hosted a ribbon-cutting for the headquarters, at 383 Main Avenue, Suite 705, in late October.

Infinant Health now has bicoastal operations, as it also has a research and innovation institute in Davis, Calif. Formerly known as Evolve Biosystems, the company had a West Coast start.

Kaile Zagger, the company’s CEO, is a Westport resident.

"Our vision at Infinant Health is to advance infant health towards longer, healthier lives for humanity – a phenomenon we hope to accelerate through the milestone opening of our executive global headquarters in Norwalk," said Zagger, in an announcement.

Zagger said the company is committed to Connecticut and to creating jobs here.

Infinant Health is focused on the role of human milk on development. It discovered B. infantis EVC001, a natural bacterial strain, which the company indicates is key to infants having a healthy microbiome and to their immune health. Its product Evivo is a probiotic for babies.

Dr. Karl Sylvester, professor of surgery and pediatrics at Stanford Medicine Children's Health and associate dean of maternal and child health research at Stanford University School of Medicine, is the company’s global medical advisor.

"Our science is clinically proven to influence the development of healthier immune systems, and I believe in our potential to one day create a world where every human immune system develops for lifelong health right from the beginning," Sylvester said. 

Infinant Health is a portfolio company of Horizons Ventures, Cargill, Manna Tree Partners, The Bill & Melinda Gates Foundation, Spruce Capital Partners, Acre Ventures, Bow Capital, Tate & Lyle Ventures and Johnson & Johnson Development Corporation.

Contact Michelle Tuccitto Sullo at

Sign up for Enews


Order a PDF